Fang S - Search Results

1

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.

Mai Z, Yuan J, Yang H, Fang S, Xie X, Wang X, Xie J, Wen J, Fu J. Mai Z, et al. Among authors: fang s. JCI Insight. 2022 Aug 22;7(16):e155218. doi: 10.1172/jci.insight.155218. JCI Insight. 2022. PMID: 35993362 Free PMC article.

2

Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy.

Zhong J, Wang K, Fang S, Fu J. Zhong J, et al. Among authors: fang s. Eur J Surg Oncol. 2021 Dec;47(12):3074-3080. doi: 10.1016/j.ejso.2021.04.026. Epub 2021 May 8. Eur J Surg Oncol. 2021. PMID: 34023168

3

Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer.

Mai Z, Liu Q, Wang X, Xie J, Yuan J, Zhong J, Fang S, Xie X, Yang H, Wen J, Fu J. Mai Z, et al. Among authors: fang s. Cancers (Basel). 2021 Dec 2;13(23):6084. doi: 10.3390/cancers13236084. Cancers (Basel). 2021. PMID: 34885197 Free PMC article.

4

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node-positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?

Fang S, Zhong J, Mai Z, Li T, Xie X, Fu J. Fang S, et al. Cancer Med. 2023 Feb;12(4):4077-4086. doi: 10.1002/cam4.5264. Epub 2022 Sep 22. Cancer Med. 2023. PMID: 36134648 Free PMC article.

5

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.

Wen J, Fang S, Hu Y, Xi M, Weng Z, Pan C, Luo K, Ling Y, Lai R, Xie X, Lin X, Lin T, Chen J, Liu Q, Fu J, Yang H. Wen J, et al. Among authors: fang s. EBioMedicine. 2022 Dec;86:104371. doi: 10.1016/j.ebiom.2022.104371. Epub 2022 Nov 23. EBioMedicine. 2022. PMID: 36434949 Free PMC article.

6

Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.

Li SB, Liu YY, Yuan L, Ji MF, Zhang A, Li HY, Tang LQ, Fang SG, Zhang H, Xing S, Li MZ, Zhong Q, Lin SJ, Liu WL, Huang P, Zeng YX, Zheng YM, Ling ZQ, Sui JH, Zeng MS. Li SB, et al. Among authors: fang sg. EMBO Mol Med. 2020 Sep 7;12(9):e12050. doi: 10.15252/emmm.202012050. Epub 2020 Jul 12. EMBO Mol Med. 2020. PMID: 32657028 Free PMC article.

7

BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma.

Fang SG, Xia TL, Fu JC, Li T, Zhong Q, Han F. Fang SG, et al. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221139981. doi: 10.1177/15330338221139981. Technol Cancer Res Treat. 2022. PMID: 36412101 Free PMC article.

8

Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.

Liu MZ, Fang SG, Huang W, Wang HY, Tian YM, Huang RD, Sun Z, Zhao C, Lu TX, Huang Y, Han F. Liu MZ, et al. Cancer Med. 2019 Aug;8(10):4633-4643. doi: 10.1002/cam4.2339. Epub 2019 Jul 3. Cancer Med. 2019. PMID: 31268626 Free PMC article.

9

Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma.

Lin J, Kong J, Luo M, Shen Z, Fang S, Hu J, Xu Z, Dong W, Huang J, Lin T. Lin J, et al. Among authors: fang s. J Clin Med. 2022 Jun 2;11(11):3188. doi: 10.3390/jcm11113188. J Clin Med. 2022. PMID: 35683570 Free PMC article.

10

Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.

Huang Y, Chen Z, Shen G, Fang S, Zheng J, Chi Z, Zhang Y, Zou Y, Gan Q, Liao C, Yao Y, Kong J, Fan X. Huang Y, et al. Among authors: fang s. Hum Vaccin Immunother. 2024 Dec 31;20(1):2318815. doi: 10.1080/21645515.2024.2318815. Epub 2024 Feb 28. Hum Vaccin Immunother. 2024. PMID: 38419524 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,187 results

Search Page